JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Rat
Purified transfected mouse B7-DC cell line
≥ 5.0 mg/ml
≥98% monomer by analytical SEC
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added.
Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUMTM antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Next Day 2-8°C
FC The suggested concentration for this CD273 antibody clone TY25 for staining cells in flow cytometry is ≤ 0.25 μg per 106 cells in a volume of 100 μl. Titration of the reagent is recommended for optimal performance for each application.WB
IHC FFIP
Clone TY25 recognizes an epitope on mouse PD-L2. TY25 does not cross-react with PD-L1.
PD-L2 is expressed on macrophages and a subset of dendritic cells (DCs).
PD-L2 antibody, clone TY25, recognizes mouse programmed death ligand 2 (PDL-2), also known as B7-DC and CD273. PD-L2 is a 42 kDa type I transmembrane glycoprotein that belongs to the B7 family of the immunoglobulin (Ig) receptor superfamily. PD-L2 is an inhibitory ligand primarily expressed on antigen-presenting cells, including macrophages and a subset of dendritic cells (DCs). Its receptor, PD-1, is expressed by CD4-CD8- thymocytes as well as CD4 and CD8 T cells, monocytes, DCs, and B cells upon activation1. Binding of PD-L2 to PD-1 on CD4 and CD8 T cells inhibits T cell receptor (TCR) signaling, negatively regulating T cell proliferation, cytokine production, and cytotoxic activity2. PD-L2 is expressed on many tumor types3, 4 and is associated with unfavorable prognosis in patients with solid tumors5.
PD-L2
PD-1, uncharacterized receptor
58205
Information on Uniprot.org
1. Francisco LM, et al. (2010) Immunol Rev. 236:219-2422. Latchman Y, et al. (2001) Nat Immunol. 2(3):261-83. Ahmad SM, et al. (2018) Oncoimmunology. 7:e13906414. Panjwani PK, et al. (2018) Hum Pathol. 71:91–95. Yang H, et al. (2019) Front Oncol. 9:47
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
Arbeitsanleitung (Data Sheet) anfordern
Produkt-Datenblatt anfordern
Sicherheitsdatenblatt anfordern
Lieferung vsl. bis 28.08.2025
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!